News Archive

Healthy food is critical to good health, but accessing and preparing nutritious food often feels complicated. A new pilot study in New Orleans funded by the American Heart Association’s Health Care by Food initiative will test out new approaches.

A recent publication in the journal Clinical Infectious Diseases highlights key takeaways from a DCRI Think Tank centered on the insights gained from the COVID-19 pandemic and 10 key steps on how this acquired knowledge can help inform the next pandemic response.

CardioHealth Alliance welcomed Merck & Co. Inc. to the CardioHealth Alliance group on November 1, aiming to further enhance evidence-based solutions for prevention and care of cardiovascular, renal and metabolic diseases.

Duke Clinical Research Institute (DCRI) faculty member Steven Z. George, PT, PhD, was recently named the next editor-in-chief of the Amerian Physical Therapy Association (APTA) scientific publication PTJ: Physical Therapy & Rehabilitation Journal.

Lesley Curtis, PhD, member in the Duke Clinical Research Institute (DCRI), chief of the Department of Population Health Sciences and professor in the Duke School of Medicine Departments of Population Health Sciences and Medicine was selected to receive the QCOR Outstanding Lifetime Achievement Award by the American Heart Association’s Council on Quality of Care and Outcomes Research (QCOR).

One of the premier scientific meetings of the year with over 10,000 clinicians and researchers in attendance, the 2023 American Heart Association Scientific Sessions focused on the latest research and insights to improve cardiovascular health. This year’s event was held in Philadelphia, Nov. 10-13. The DCRI was represented in poster sessions, moderated digital poster sessions, debates, simulations, learning labs and main stage presentations.

Researchers from the Duke Clinical Research Institute (DCRI) were once again named to Clarivate's Most Highly Cited Scientists list.

By randomizing 10,000 adult patients, ARTEMIS will evaluate the effects of a study medicine versus placebo on cardiovascular outcomes in patients with acute myocardial infarction.

An antibiotic that has shown effectiveness for bacterial pneumonia also appears successful in fighting methicillin-resistant staph infections, reports a team led by Duke Health. The drug, ceftobiprole, showed similar benefit when tested against the antibiotic daptomycin to treat complicated Staphylococcus aureus bacterial infections. If approved by the FDA, ceftobiprole could provide another line of defense against a common and often deadly bacterial infection.

When it comes to COVID-19 testing and vaccination, not all Hispanic populations respond the same.